Inhibitors of anthrax lethal factor

ORGN 916

Brandon D. Gaddis, bgaddis@purdue.edu and Jean A. Chmielewski, chml@purdue.edu. Department of Chemistry, Purdue University, West Lafayette, IN 47906
Anthrax, a disease caused by Bacillus anthracis, has come to worldwide attention as a biological weapon in recent years. Anthrax lethal toxin, consisting of protective antigen, lethal factor, and edema factor is the causative agent of anthrax pathogenesis. Recently, agents were identified that rescued cells from anthrax lethal toxin mediated cell death via a medium throughput cell-based screen. Secondary in vitro assays were used to determine the molecular targets of each agent. Compounds were identified that selectively inhibited anthrax lethal factor (LF). An SAR study based upon lethal factor inhibitor N-oleoyldopamine (OLDA, 1) produced additional LF inhibitors with good cell activity and low cellular cytotoxicity. Mechanistic studies identified these compounds as uncompetitive inhibitors with the most potent agent having a Ki value of 1.7 + 0.1 μM.

aa.gif